NCT00004399View on ClinicalTrials.gov

Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia

NACompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 30, 1995

Study Completion Date

August 31, 2000

Conditions
Pre-eclampsia
Interventions
DRUG

magnesium sulfate

DRUG

nimodipine

All Listed Sponsors
collaborator

University of Utah

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004399 - Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia | Biotech Hunter | Biotech Hunter